Markets
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev
- Trade
- Markets
- Copy
- Contests
- 24/7
- Calendar
- Q&A
- Chats
SYMBOL
LAST
BID
ASK
HIGH
LOW
NET CHG.
%CHG.
SPREAD
SPX
S&P 500 Index
6556.36
6556.36
6556.36
6595.74
6525.12
-24.64
-0.37%
--
DJI
Dow Jones Industrial Average
46124.05
46124.05
46124.05
46400.82
45769.69
-84.41
-0.18%
--
IXIC
NASDAQ Composite Index
21761.88
21761.88
21761.88
21916.16
21712.04
-184.87
-0.84%
--
USDX
US Dollar Index
99.020
99.020
99.100
99.410
98.800
+0.150
+ 0.15%
--
EURUSD
Euro / US Dollar
1.16120
1.16120
1.16129
1.16187
1.16006
+0.00057
+ 0.05%
--
GBPUSD
Pound Sterling / US Dollar
1.34127
1.34127
1.34137
1.34222
1.34015
+0.00022
+ 0.02%
--
XAUUSD
Gold / US Dollar
4539.37
4539.37
4539.81
4551.18
4455.91
+63.95
+ 1.43%
--
WTI
Light Sweet Crude Oil
88.103
88.103
88.133
88.526
87.046
+0.522
+ 0.60%
--
- All
- Chatrooms
- Groups
- Friends
Connecting
.
.
.
- All
- Russia-Ukraine Conflict
- Middle East Flashpoint
Best Stocks Under $1 With Huge Potential: Top Penny Stocks to Watch in 2024
Summary:
Explore the best stocks under $1 with massive potential in 2024. Learn about penny stocks in renewable energy, biotech, fintech, and more. High risk, high reward.
Investing in penny stocks—stocks priced under $1—can be an exciting, albeit risky, way to diversify your portfolio and potentially achieve high returns. While these stocks are often viewed as speculative, the allure of finding a small company with the potential for explosive growth continues to attract investors. In this article, we will delve into some of the best stocks under $1 in 2024 that offer significant potential and examine the factors that make them worth considering.
What Are Penny Stocks?
Penny stocks are shares of small companies that trade at low prices, typically under $5, and often under $1. These stocks are usually traded on over-the-counter (OTC) exchanges, although some may trade on major exchanges like the NASDAQ or the NYSE. Penny stocks come with high volatility, low liquidity, and a speculative nature, but they also offer the possibility of substantial gains.
Factors to Consider Before Investing in Penny Stocks
Risk and Volatility: Penny stocks are often tied to smaller companies with fewer resources and less established track records, leading to higher risks.
Liquidity Issues: With low trading volumes, penny stocks may experience significant price swings, and selling them can be challenging.
Research and Due Diligence: In-depth research is crucial. Investors should look into the company's financials, management team, and market potential before investing.
Now that we’ve covered the basics, let's look at some of the best stocks under $1 in 2024 with significant upside potential.
1. SunHydrogen Inc. (OTCMKTS: HYSR)
Industry: Renewable Energy
Price: $0.07 (as of October 2024)
Market Cap: $100 million
SunHydrogen is a company that focuses on developing renewable hydrogen technologies. The company is working on a breakthrough process to produce hydrogen using sunlight and water. With the growing demand for clean energy solutions and governments worldwide pushing for carbon neutrality, SunHydrogen has positioned itself as a potential long-term play in the green energy sector.
Why It Has Potential:
Hydrogen is considered one of the most promising renewable energy sources for the future.
If SunHydrogen can scale its technology, the stock could see significant upside as global clean energy adoption increases.
2. Acasti Pharma Inc. (NASDAQ: ACST)
Industry: Biotechnology
Price: $0.65 (as of October 2024)
Market Cap: $80 million
Acasti Pharma is a biopharmaceutical company that focuses on developing therapies for rare diseases. The company’s lead candidate, GTX-104, is aimed at treating acute coronary syndrome, a condition associated with heart attacks. With an aging global population and a high demand for innovative health solutions, Acasti Pharma has the potential to capture a niche market in the biotech space.
Why It Has Potential:
The company is targeting an unmet medical need with a strong focus on cardiovascular health.If its pipeline products progress successfully through clinical trials, Acasti Pharma could experience a significant price jump.
3. Triterras Inc. (OTCMKTS: TRITF)
Industry: Fintech
Price: $0.92 (as of October 2024)
Market Cap: $60 million
Triterras is a fintech company that operates a blockchain-enabled trade and finance platform. It aims to revolutionize trade finance, a $10 trillion industry, by providing a more secure, transparent, and efficient way to facilitate cross-border transactions. Despite facing some challenges in recent years, the company’s blockchain-based platform holds promise, especially as blockchain technology becomes more widely accepted.
Why It Has Potential:
Triterras operates in a rapidly growing fintech sector, with blockchain technology seen as the future of global trade finance.The company has already established a working product, and any further positive developments could send the stock higher.
4. Advaxis, Inc. (OTCMKTS: ADXS)
Industry: Biotechnology
Price: $0.30 (as of October 2024)
Market Cap: $25 million
Advaxis is a clinical-stage biotechnology company developing cancer immunotherapies. The company has several immunotherapy candidates in its pipeline targeting a range of cancers, including cervical cancer and head and neck cancers. While still in the early stages of development, Advaxis could be a major player in the biotech space if its treatments prove effective in clinical trials.
Why It Has Potential:
Cancer treatment remains one of the most lucrative markets in the biotech sector.If Advaxis can demonstrate successful trial results, the stock could see a significant increase in valuation.
5. Zomedica Corp. (NYSE: ZOM)
Industry: Veterinary Health
Price: $0.45 (as of October 2024)
Market Cap: $80 million
Zomedica is a veterinary health company that develops products for companion animals. The company's flagship product, Truforma, is a diagnostic platform designed to help veterinarians quickly and accurately diagnose diseases in pets. With the growing pet care industry and increased spending on pet health, Zomedica has carved out a niche market that could lead to substantial growth.
Why It Has Potential:
The pet care industry is booming, with pet owners spending more on healthcare services for their animals.
Zomedica's innovative diagnostic tools give it a competitive edge in the veterinary market.
6. Nano Dimension Ltd. (NASDAQ: NNDM)
Industry: 3D Printing Technology
Price: $0.95 (as of October 2024)
Market Cap: $500 million
Nano Dimension is a leader in the development of 3D printing technologies for the electronics industry. Their technology is used to print circuit boards, and they have seen increased demand as more industries move towards additive manufacturing. With a strong emphasis on innovation and R&D, Nano Dimension is positioned to capitalize on the growing demand for advanced manufacturing solutions.
Why It Has Potential:
The 3D printing industry is experiencing rapid growth, with applications across multiple sectors.
Nano Dimension's proprietary technology has the potential to disrupt traditional manufacturing processes, creating new growth opportunities.
Conclusion
Penny stocks priced under $1 can offer incredible opportunities for growth, but they come with significant risks. Investors must conduct thorough research and remain aware of the high volatility associated with these stocks. In 2024, companies like SunHydrogen, Acasti Pharma, and Triterras are just a few of the stocks that, despite their low prices, hold significant upside potential. Whether in biotech, fintech, or renewable energy, these stocks have positioned themselves in industries with immense growth prospects. However, as with any investment, careful consideration and risk management are crucial.
To stay updated on all economic events of today, please check out our Economic calendar
Risk Warnings and Disclaimers
You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
Copyright © 2026 FastBull Ltd
728 RM B 7/F GEE LOK IND BLDG NO 34 HUNG TO RD KWUN TONG KLN HONG KONG
Risk Disclosure
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.
Not Logged In
Log in to access more features
Become a signal provider
Help Center
Dark Mode
Price Up/Down Colors
Log In
Sign Up